Company / Current Liabilities
vTv Therapeutics Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$6.6M
FY2025
5-year range
$5.2M / $10.6M
FY2021-FY2025
Trend
+27.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 10 years, ranging from $5M in FY2024 to $27M in FY2017.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +0.8%.
Improved from $11M to $7M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, current liabilities increased 27.8% year-over-year.
- Peak current liabilities was recorded in FY2017.
- Lowest current liabilities in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.6M | +27.8% |
| FY2024 | $5.2M | -51.1% |
| FY2023 | $10.6M | +37.8% |
| FY2022 | $7.7M | -9.3% |
| FY2021 | $8.5M | +33.0% |
| FY2020 | $6.4M | -52.2% |
| FY2019 | $13.4M | -29.0% |
| FY2018 | $18.8M | -30.0% |
| FY2017 | $26.9M | +135.5% |
| FY2016 | $11.4M | +48.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026